Neurizon Opens Share Plan, Allows SPP to Raise Up to $10 Million
NUZ: $0.059 +1.72% · MC: $48M
Neurizon has opened its share purchase plan, targeting $2 million at the same price as its recent placement, while reserving the right to accept oversubscriptions up to $10 million; the offer is not underwritten and may be scaled back. Eligible shareholders may also be offered one option for each share subscribed for, subject to shareholder approval and ASX quotation requirements. Proceeds are intended to support clinical work, including the HEALEY ALS trial, whose topline results are anticipated in late Q2 CY2027.

Comments